Skip to main content

Table 8 Other FDA-approved anti-cancer therapies at the time of study but not used in the studied population

From: Off-label use of cancer therapies in women diagnosed with breast cancer in the United States

Category Drug name
Chemotherapies Altretamine, Asparaginase, Bendamustine, Busulfan, Decitabine, Estramustine, Floxuridine, Liposomal Cytarabine, Lomustine, Nelarabine, Pegaspargase, Pentostatin, Procarbazine, Temozolomide, Teniposide, Thioguanine, Valrubicin
Hormone therapies Bicalutamide, Degarelix, Flutamide, Histrelin, Nilutamide, Toremifene, Triptorelin
Targeted therapies Dasatinib, Everolimus, Lapatinib, Nilotinib, Sorafenib, Temsirolimus, Vironostat. Bexarotene, Tretinoin
Immunotherapies BCG, Ibritumomab, Imiquimod, Interferon alfa-2a, Lenalidomide, Tositumomab